Merck KGaA Collaborates with GenScript for the Expansion of Cell and Gene Therapies in China

 Merck KGaA Collaborates with GenScript for the Expansion of Cell and Gene Therapies in China

Merck KGaA Collaborates with GenScript for the Expansion of Cell and Gene Therapies in China

Shots:

  • Merck KGaA & GenScript enter into a collaboration agreement to accelerate the industrialization and commercialization of cell and gene therapy in China. Merck to provide products, services & staff training from lab development to large-scale GMP manufacturing to GenScript
  • The focus of the collaboration is to develop a global platform for plasmid and virus manufacturing with the establishment of cGMP manufacturing facilities in China
  • Additionally, the companies plan to develop a unit focusing on commercialization and manufacturing of these gene therapy products in China

Click here to read full press release/ article | Ref: Merck KGaA | Image: Amge

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post